Drawing for ZANTAC GELDOSE

USPTO serial 74250652

ZANTAC GELDOSE

Reviewed by CopyMark Law Group

Reg. 1924404Status 711
Filing date
Status date
Registration date
Oct 3, 1995
Examiner
LEVINE, HOWARD B
Law office
FILE REPOSITORY (FRANCONIA)

What this means

This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.

Need help with ZANTAC GELDOSE?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

JANE UNGARO

JANE UNGARO PFIZER INC201 TABOR RDMORRIS PLAINS, NJ 07950-2693UNITED STATES

Goods and services

ClassDescriptionStatusFirst use
005pharmaceutical preparations for the treatment and/or alleviation of ulcers and gastrointestinal disordersSECTION 7(e) - CANCELLEDMay 16, 1994

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Mar 15, 2002C7..CANCELLED SECTION 7-TOTAL—
Jan 17, 2002C7RFREQUEST FOR SECT 7 TOTAL SURRENDER FILED—
Oct 3, 1995R.PRREGISTERED-PRINCIPAL REGISTERYour trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive.
Jul 20, 1995CNPRALLOWED PRINCIPAL REGISTER - SOU ACCEPTED—
May 25, 1995CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Feb 25, 1995CNRTNON-FINAL ACTION MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Nov 29, 1994CNRTNON-FINAL ACTION MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Oct 19, 1994SUPCSTATEMENT OF USE PROCESSING COMPLETE—
Oct 19, 1994EX4GSOU EXTENSION 4 GRANTED—
Sep 6, 1994IUAFUSE AMENDMENT FILED—
Sep 6, 1994EXT4SOU EXTENSION 4 FILED—
Aug 19, 1994EX3GSOU EXTENSION 3 GRANTED—
Jul 8, 1994EXT3SOU EXTENSION 3 FILED—
Dec 29, 1993EX2GSOU EXTENSION 2 GRANTED—
Nov 5, 1993EXT2SOU EXTENSION 2 FILED—
Jul 21, 1993EX1GSOU EXTENSION 1 GRANTED—
May 28, 1993EXT1SOU EXTENSION 1 FILED—
Jan 12, 1993NOAMNOA MAILED - SOU REQUIRED FROM APPLICANTA Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date.
Oct 20, 1992PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Sep 18, 1992NPUBNOTICE OF PUBLICATION—
Jun 15, 1992CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Jun 3, 1992CNEAEXAMINER'S AMENDMENT MAILED—
May 19, 1992CNRTNON-FINAL ACTION MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
May 6, 1992DOCKASSIGNED TO EXAMINER—
May 4, 1992DOCKASSIGNED TO EXAMINER—

Frequently asked questions

Related guidance